Douglas A. Hastings Esq.

Epstein Becker & Green, P.C.
Hastings, Douglas

Doug Hastings, the Chair Emeritus of Epstein Becker & Green, P.C., is a nationally recognized health care transaction lawyer and adviser on health system change. For more than 30 years, Mr. Hastings and his colleagues at Epstein Becker Green have designed, implemented, and successfully closed scores of complex health care transactions on behalf of hospitals, health systems, academic medical centers, post-acute providers, large medical groups, and health plans. He advises clients on the strategic considerations, corporate architecture, and regulatory compliance components of proposed transactions, including the payment and delivery reform, governance, antitrust, exempt tax, and fraud and abuse implications.

Mr. Hastings served on the Board on Health Care Services of the Institute of Medicine (IOM) from 2003-11 and on the IOM's Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care from 2010-13. He is a Past President and Fellow of the American Health Lawyers Association. Named in 2006 as the first Chair of the Board of Directors of Epstein Becker Green, Mr. Hastings served in that role until January 2014.

Currently, Mr. Hastings serves as a member of the Board of Directors of Guthrie Health and the Quality and Community Benefit Committee of Riverside Health System. In 2013, he was elected to membership in the Healthcare Executives Study Society, a group primarily comprised of large health system CEOs that seeks to advance the state and art of executive leadership and influence the development of health care public policy.

He earned a B.A. from Duke University and his J.D. from the University of Virginia Law School.

Mr. Hastings is the co-author of the Bloomberg BNA Health Law & Business Portfolio Series No. 2300, Regulation of Provider Risk Sharing and Other Limitations on Risk Bearing Provider Networks.